Your browser doesn't support javascript.
loading
Occluded vein as a predictor for complications in non-infectious transvenous lead extraction.
Milman, Anat; Leshem, Eran; Massalha, Eias; Jia, Karen; Meitus, Amit; Kariv, Saar; Shafir, Yuval; Glikson, Michael; Luria, David; Sabbag, Avi; Beinart, Roy; Nof, Eyal.
Afiliação
  • Milman A; Leviev Heart Institute, The Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Leshem E; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Massalha E; Leviev Heart Institute, The Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Jia K; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Meitus A; Leviev Heart Institute, The Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Kariv S; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shafir Y; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Glikson M; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Luria D; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Sabbag A; Leviev Heart Institute, The Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Beinart R; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Nof E; The Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel.
Front Cardiovasc Med ; 9: 1016657, 2022.
Article em En | MEDLINE | ID: mdl-36312249
ABSTRACT

Background:

The use of cardiovascular implantable electronic device (CIED) is steadily increasing, and complications include venous occlusion and fractured leads. Transvenous lead extraction (TLE) can facilitate the re-implantation of new leads.

Aims:

This study aims to explore predictors and complications of non-infectious TLE.

Methods:

This study involves a retrospective analysis and comparison of characteristics, complications, and outcomes of patients with and without occluded veins (OVs) undergoing TLE at our center.

Results:

In total, eighty-eight patients underwent TLE for non-infectious reasons. Indications for TLE were lead malfunction (62; 70.5%) and need for CIED upgrade (22; 25%). Fourteen patients referred due to lead malfunction had an OV observed during venography. The OV group (36 patients) were significantly older (65.7 ± 14.1 vs. 53.8 ± 15.9, p = 0.001) and had more comorbidities. Ejection fraction (EF) was significantly lower for the OV group (27.5 vs. 57.5%, p = 0.001) and had a longer lead dwelling time (3,226 ± 2,324 vs. 2,191 ± 1,355 days, p = 0.012). Major complications were exclusive for the OV group (5.5% vs. none, p = 0.17), and most minor complications occurred in the OV group as well (33.3 vs. 4.1%, p < 0.001). Laser sheath and mechanical tools for TLE were frequently used for OV as compared to the non-occluded group (94.4 vs. 73.5%, respectively, p = 0.012). Procedure success was higher in the non-occluded group compared to the OV group (98 vs. 83.3%, respectively, p = 0.047). Despite these results, periprocedural mortality was similar between groups.

Conclusion:

Among the TLE for non-infectious reasons, vein occlusion appears as a major predictor of complex TLE tool use, complications, and procedural success. Venography should be considered prior to non-infectious TLE to identify high-risk patients.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article